| Symbol | LIVN |
|---|---|
| Name | LIVANOVA PLC |
| Sector | HEALTH CARE |
| Region | Europe |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Address | 20 EASTBOURNE TERRACE, LONDON, W2 6LG, United Kingdom |
| Telephone | +44 20 33250660 |
| Fax | — |
| — | |
| Website | https://www.livanova.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001639691 |
| Description | LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients healthcare professionals and healthcare systems. At LivaNova we understand the importance of bringing both clinical and economic value to our customers. We are a strong market-leading medical technology and services company offering a diverse product portfolio and global reach. LivaNova is listed on the NASDAQ stock exchange under the ticker symbol LIVN. LivaNova has approximately 3000 employees worldwide. We are headquartered in London UK and maintain a presence in more than 100 countries. LivaNova is a worldwide leader in advanced circulatory support cardiopulmonary and neuromodulation dedicated to creating meaningful products and therapies that transform lives each and every day. Additional info from NASDAQ: |
2026-05-19 12:00
LivaNova to Present at Goldman Sachs Global Healthcare Conference in June
Read more
2026-05-06 14:04
New Form IRANNOTICE - LivaNova PLC <b>Filed:</b> 2026-05-06 <b>AccNo:</b> 0001639691-26-000037 <b>Size:</b> 45 KB
Read more
2026-05-06 10:00
LivaNova Reports First-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance
Read more
2026-04-29 09:34
New Form ARS - LivaNova PLC <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 0001104659-26-050946 <b>Size:</b> 1 MB
Read more
2026-04-29 09:32
New Form DEFA14A - LivaNova PLC <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 0001104659-26-050942 <b>Size:</b> 712 KB
Read more
2026-04-29 09:31
New Form DEF 14A - LivaNova PLC <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 0001104659-26-050937 <b>Size:</b> 8 MB
Read more
2026-04-20 21:05
Annals of Internal Medicine Publishes 12-Month Results from LivaNova’s OSPREY Clinical Study for Obstructive Sleep Apnea
Read more
2026-04-01 21:20
Poletti Franco 🟡 adjusted position in 1.4K shares (4 derivative) of LivaNova PLC (LIVN) at $61.27 Transaction Date: Mar 30, 2026 | Filing ID: 000026
Read more
2026-04-01 21:20
Director Makatsaria Vladimir 🟡 adjusted position in 93.3K shares (7 derivative) of LivaNova PLC (LIVN) at $61.27 Transaction Date: Mar 30, 2026 | Filing ID: 000024
Read more
2026-04-01 21:20
Bolton Stephanie 🟡 adjusted position in 9.6K shares (11 derivative) of LivaNova PLC (LIVN) at $61.27 Transaction Date: Mar 30, 2026 | Filing ID: 000023
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT02870647 | Sleep Apnea, Arrhythmias and Cardiac Reverse Remodeling in Heart Failure Patien… | Phase4 | Sleep Breathing Disorders in the Responders to Cardiac Resynchronisation Therapy (CRT) | Withdrawn | — | 2020-03-01 | ClinicalTrials.gov |
| NCT05952674 | Treatment Resistant Depression and Vagus Nerve Stimulation | Na | Treatment Resistant Depression (TRD) | Recruiting | 2024-09-19 | 2030-08-19 | ClinicalTrials.gov |
| NCT05975931 | IMPACT of AspireSR® for VNS Therapy on Healthcare Resource Utilisation and Clin… | — | Epilepsy | Terminated | 2022-01-20 | 2024-01-30 | ClinicalTrials.gov |
| NCT04950894 | Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation | Na | Obstructive Sleep Apnea | Active_Not_Recruiting | 2021-07-27 | 2025-10-30 | ClinicalTrials.gov |
| NCT04779814 | Non-interventional Study Describing Healthcare Resource Utilisation and Clinica… | — | Epilepsy | Terminated | 2021-05-11 | 2025-08-19 | ClinicalTrials.gov |
| NCT03953768 | VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems | Na | Autoimmune Diseases | Recruiting | 2021-04-01 | 2026-12-31 | ClinicalTrials.gov |
| NCT04753385 | The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols… | — | Treatment Resistant Depression | Terminated | 2021-03-23 | 2024-09-06 | ClinicalTrials.gov |
| NCT04282681 | XLTCS - Accelerometer Data Collection in an Epilepsy Monitoring Unit (EMU) | — | Epilepsy, Tonic-Clonic | Withdrawn | 2020-03-16 | 2022-02-28 | ClinicalTrials.gov |
| NCT03887715 | A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating … | Na | Treatment Resistant Depression | Recruiting | 2019-09-26 | 2030-12-31 | ClinicalTrials.gov |
| NCT03425422 | ANTHEM-HFrEF Pivotal Study | Na | Heart Failure | Terminated | 2018-05-01 | 2023-05-31 | ClinicalTrials.gov |
| NCT03446664 | Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study | Na | Epilepsies, Partial | Completed | 2018-02-27 | 2021-10-27 | ClinicalTrials.gov |
| NCT03529045 | Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Ther… | — | Epilepsy | Completed | 2018-02-05 | 2024-09-11 | ClinicalTrials.gov |
| NCT03320304 | A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With … | — | Treatment Resistant Depression | Recruiting | 2017-12-14 | 2031-12-01 | ClinicalTrials.gov |
| NCT03200574 | Behavior of Valve Leaflets Following Aortic Valve Implant | Na | Aortic-valve Replacement | Completed | 2017-12-06 | 2021-02-25 | ClinicalTrials.gov |
| NCT03014180 | Clinical Evaluation of LEft VEntricular Auto Threshold Algorithm (LEVEA) | Na | Heart Failure | Completed | 2017-02-16 | 2017-08-17 | ClinicalTrials.gov |
| NCT02751021 | Sleep Apnea Diagnosis Using a Novel Pacemaker Algorithm and Link With Aldostero… | Na | Sleep Apnea | Completed | 2016-06-22 | 2019-06-01 | ClinicalTrials.gov |
| NCT02789748 | PErsonalized and Adaptive Kinesthetic stImulation Therapy, Based on Cardio-resp… | Na | Obstructive Sleep Apnea Syndrome | Completed | 2016-06-01 | 2017-10-02 | ClinicalTrials.gov |
| NCT02577445 | The remedē® System for the Treatment of Central Sleep Apnea in Daily Practice | — | Sleep Apnea | Terminated | 2016-02-01 | 2016-10-01 | ClinicalTrials.gov |
| NCT02650232 | Pilot Study to Evaluate the Somnotouch Device to Quantify Spontaneous Barorefle… | Na | Healthy | Completed | 2015-12-01 | 2018-12-01 | ClinicalTrials.gov |
| NCT03338582 | STIMTAVI : Evolution of Atrioventricular Conduction Disorders After TAVI | — | Pacemaker Implantation | Unknown | 2015-11-01 | 2018-04-19 | ClinicalTrials.gov |
| NCT02482844 | Assessment of the Prognosis of Persistent Left Bundle Branch Block (LBBB)After … | Phase4 | Post-TAVI | Unknown | 2015-06-01 | 2017-12-01 | ClinicalTrials.gov |
| NCT02351726 | Mitroflow DL Post Approval Study- North America | Na | Aortic Stenosis | Terminated | 2015-03-01 | 2019-12-31 | ClinicalTrials.gov |
| NCT02263859 | Targeted Hypoglossal Neurostimulation Study #3 | Na | Obstructive Sleep Apnea | Completed | 2015-02-01 | 2023-09-01 | ClinicalTrials.gov |
| NCT02113033 | VAgal Nerve Stimulation: safeGUARDing Heart Failure Patients | Phase2 | Heart Failure With Reduced Ejection Fraction | Completed | 2014-10-07 | 2016-09-20 | ClinicalTrials.gov |
| NCT03300037 | HYpopnea and Apnea Detection and Treatment Performance of a New cardiOreSpirato… | — | Sleep Apnea, Obstructive | Completed | 2014-09-01 | 2015-04-16 | ClinicalTrials.gov |
| NCT01987635 | Assessment of Sustained Systolic-to-diastolic Flexibility of the Mitral Valve A… | Na | Mitral Valve Disease | Completed | 2014-01-16 | 2018-09-28 | ClinicalTrials.gov |
| NCT03127202 | Left Ventricular Pacing Vectors Effectiveness to Narrow Phrenic Nerve Stimulati… | Na | Heart Failure | Completed | 2012-11-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01731210 | Clinical Evaluation Of The Nano Lv Lead System In Chronic Situation (LENEA) | Phase2 | LV Lead | Terminated | 2012-10-31 | 2013-12-19 | ClinicalTrials.gov |
| NCT02250547 | Optimization With SonR Method in the ClinicAl pRactice | — | CRT Patients | Completed | 2012-07-01 | 2017-09-01 | ClinicalTrials.gov |
| NCT02586480 | Evolution of the PR Interval in Patients Implanted With a Pacemaker Using the S… | — | Sinus Node Dysfunction | Completed | 2012-04-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01537718 | Evaluation of the Performances of the Sleep Disordered Breathing Monitoring Fun… | Phase3 | Bradycardia | Completed | 2012-03-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT01341522 | Clinical Evaluation of the Sorin Group's REPLY MR-conditional Pacing System | Phase3 | Dual-chamber Pacemaker Placement | Withdrawn | 2012-01-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT01437371 | Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Yea… | Phase3 | Heart Failure | Completed | 2011-08-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01293526 | Acute Optimization of Cardiac Resynchronization Therapy (CRT)Using Echocardiogr… | Na | Heart Failure | Withdrawn | 2011-02-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01287234 | Atrio-Ventricular (AV) Delay Optimization Using Echocardiography Versus the Son… | Na | Heart Failure | Completed | 2011-01-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01169272 | Clinical Evaluation Of The SonR Atrial Lead In Paradym RF Device | Phase3 | Heart Failure | Completed | 2010-10-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01193634 | Clinical Evaluation Of The PARADYM RF Device | Phase3 | Heart Failure | Completed | 2010-10-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT02253134 | Monitoring of Syncopes and/or Sustained Palpitations of Suspected Arrhythmic Or… | — | Syncope | Completed | 2010-08-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT01121341 | ESOS (Endoscopic Saphenous Harvesting With an Open CO2 System) Trial | Phase4 | Coronary Artery Bypass Grafting Surgery | Unknown | 2010-05-01 | — | ClinicalTrials.gov |
| NCT01944514 | Implantable Cardioverter Defibrillators - Improving Risk Stratification | — | Sudden Cardiac Death | Completed | 2010-01-01 | — | ClinicalTrials.gov |
| NCT01170624 | Clinical Status Monitoring in Implantable Cardiac Defibrillator (ICD) Patients … | Phase4 | Heart Failure | Terminated | 2009-09-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT00957541 | Evaluation of a Diagnostic Feature in a Cardiac Resynchronization Therapy (CRT)… | Phase2 | Congestive Heart Failure | Completed | 2009-09-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT02167789 | Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT … | Phase3 | Heart Failure | Completed | 2009-09-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT01185392 | European Cardiac Resynchronisation Therapy Survey | — | Heart Failure | Completed | 2008-11-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT00736294 | Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After R… | Phase3 | Atrial Fibrillation | Terminated | 2008-07-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01168518 | An Observational Study on the Sorin Group New Brady Leads XFine and Beflex | — | Pacing Leads Implantation | Completed | 2008-07-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT00560768 | Predictive Risk Stratification Through T Variability in ICD Patients Without Pa… | Phase4 | Sudden Cardiac Death | Completed | 2007-12-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT00562107 | Evaluation of the SafeR Mode in Patients With a Dual Chamber Pacemaker Indicati… | Phase4 | Assess the Benefits From the AAISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients. | Completed | 2007-12-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT01169896 | Impact of Ventricular Pacing in Unselected ICD/CRT-D Patients | — | Ventricular Tachycardia | Completed | 2007-11-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01066078 | Echocardiography and Peak Endocardial Acceleration (PEA) Measurements in Cardia… | — | Congestive Heart Failure | Completed | 2007-10-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00531037 | Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac… | — | Patients Implanted With a Pacemaker | Completed | 2007-06-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT00377871 | Hemodynamic Performance in Stentless Heart Valves | Na | Heart Valve Diseases | Completed | 2007-05-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00703963 | Improved Time in Therapeutic Range With Patient Self-Testing of Their INR Compa… | Na | Management of Anticoagulation | Completed | 2007-03-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00729703 | Optimal Anti-tachycardia Therapy in Implantable Cardioverter-defibrillator (ICD… | Phase4 | Tachycardia | Completed | 2006-06-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT00729235 | Biventricular Tachycardias Outcome Trial | Phase4 | Biventricular Tachycardias | Completed | 2006-05-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT00658203 | Clinical Evaluation on Advanced Resynchronization | Phase4 | Heart Failure | Completed | 2005-11-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT01170611 | Prevention of Atrial Arrhythmia in Patients Without Atrioventricular (AV) Condu… | Phase4 | Sinus Node Dysfunction | Completed | 2004-07-01 | 2007-01-01 | ClinicalTrials.gov |
| NCT00708786 | Ventricular Arrhythmias Incidence According to Sleep Apnea Syndrome in Implanta… | Phase4 | Sleep Apnoea | Completed | 2004-04-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00655213 | Spontaneous Atrio Ventricular Conduction Preservation | Phase4 | Sinus Node Dysfunction | Completed | 2003-11-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT00432536 | Redesigning Cardiac Surgery to Reduce Neurologic Injury | — | Cardiovascular Disease | Completed | 2002-10-01 | 2012-02-01 | ClinicalTrials.gov |
Total clinical trials: 60
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Vein harvesting | Other | Phase PHASE4 | Coronary Artery Bypass Grafting Surgery | UNKNOWN | NCT01121341 |
| Vein harvesting | Other | Phase PHASE4 | Coronary Artery Bypass Grafting Surgery | UNKNOWN | NCT01121341 |
| Vein harvesting | Other | Phase PHASE4 | Coronary Artery Bypass Grafting Surgery | UNKNOWN | NCT01121341 |
| Symphony DR 2550 | Other | Phase PHASE4 | Sinus Node Dysfunction | COMPLETED | NCT00655213 |
| Symphony D 2450 | Other | Phase PHASE4 | Sinus Node Dysfunction | COMPLETED | NCT00655213 |
| Symphony DR 2550 | Other | Phase PHASE4 | Sinus Node Dysfunction | COMPLETED | NCT00655213 |
| Symphony D 2450 | Other | Phase PHASE4 | Sinus Node Dysfunction | COMPLETED | NCT00655213 |
| New Living CHF | Other | Phase PHASE4 | Heart Failure | COMPLETED | NCT00658203 |
| New Living CHF | Other | Phase PHASE4 | Heart Failure | COMPLETED | NCT00658203 |
| CRT-D | Other | Phase PHASE4 | Sleep Apnoea | COMPLETED | NCT00708786 |
| ICD | Other | Phase PHASE4 | Sleep Apnoea | COMPLETED | NCT00708786 |
| CRT-D | Other | Phase PHASE4 | Sleep Apnoea | COMPLETED | NCT00708786 |
| ICD | Other | Phase PHASE4 | Sleep Apnoea | COMPLETED | NCT00708786 |
| Echocardiography and SonR recording | Other | Preclinical | Congestive Heart Failure | COMPLETED | NCT01066078 |
| PACEMAKER SYMPHONY 2550 | Other | Phase PHASE4 | Sinus Node Dysfunction | COMPLETED | NCT01170611 |
| PACEMAKER SYMPHONY 2550 | Other | Phase PHASE4 | Sinus Node Dysfunction | COMPLETED | NCT01170611 |
| Ovatio CRT 6750 | Other | Phase PHASE4 | Biventricular Tachycardias | COMPLETED | NCT00729235 |
| Ovatio CRT 6750 | Other | Phase PHASE4 | Biventricular Tachycardias | COMPLETED | NCT00729235 |
| Echocardiogram/SonR | Other | Approved | Heart Failure | COMPLETED | NCT01287234 |
| Echocardiogram/SonR | Other | Approved | Heart Failure | COMPLETED | NCT01287234 |
| REPLY 200 | Other | Phase PHASE3 | Bradycardia | COMPLETED | NCT01537718 |
| REPLY 200 | Other | Phase PHASE3 | Bradycardia | COMPLETED | NCT01537718 |
| control | Other | Phase PHASE3 | Dual-chamber Pacemaker Placement | WITHDRAWN | NCT01341522 |
| MRI exam | Other | Phase PHASE3 | Dual-chamber Pacemaker Placement | WITHDRAWN | NCT01341522 |
| control | Other | Phase PHASE3 | Dual-chamber Pacemaker Placement | WITHDRAWN | NCT01341522 |
| MRI exam | Other | Phase PHASE3 | Dual-chamber Pacemaker Placement | WITHDRAWN | NCT01341522 |
| Paradym CRT + Physiological Diagnosis (PhD) | Other | Phase PHASE2 | Congestive Heart Failure | COMPLETED | NCT00957541 |
| Paradym CRT + Physiological Diagnosis (PhD) | Other | Phase PHASE2 | Congestive Heart Failure | COMPLETED | NCT00957541 |
| VR 9250 / DR 9550 / CRT 9750 | Other | Phase PHASE3 | Heart Failure | COMPLETED | NCT01193634 |
| CRT-SonR 9770 | Other | Phase PHASE3 | Heart Failure | COMPLETED | NCT01169272 |
| CRT-SonR 9770 | Other | Phase PHASE3 | Heart Failure | COMPLETED | NCT01169272 |
| CRT-SonR 9770 | Other | Phase PHASE3 | Heart Failure | COMPLETED | NCT01169272 |
| Paradym CRT 8770 | Other | Phase PHASE3 | Heart Failure | COMPLETED | NCT02167789 |
| Paradym CRT 8770 | Other | Phase PHASE3 | Heart Failure | COMPLETED | NCT02167789 |
| Paradym CRT 8770 | Other | Phase PHASE3 | Heart Failure | COMPLETED | NCT02167789 |
| Usual Care | Other | Approved | Management of Anticoagulation | COMPLETED | NCT00703963 |
| INRatio monitor by Hemosense | Other | Approved | Management of Anticoagulation | COMPLETED | NCT00703963 |
| Symphony DR 2550 and REPLY DR cardiac pacemakers | Other | Phase PHASE4 | Assess the Benefits From the AAISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients. | COMPLETED | NCT00562107 |
| Symphony DR 2550 and REPLY DR cardiac pacemakers | Other | Phase PHASE4 | Assess the Benefits From the AAISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients. | COMPLETED | NCT00562107 |
| - Angiotensin conversing enzyme inhibitors: enalapril, captopril, lisinopril, ramipril, trandolapril. | Other | Phase PHASE3 | Heart Failure | COMPLETED | NCT01437371 |
| - Angiotensin conversing enzyme inhibitors: enalapril, captopril, lisinopril, ramipril, trandolapril. | Other | Phase PHASE3 | Heart Failure | COMPLETED | NCT01437371 |
| Cardiac Resynchronization Therapy -Defibrillator (range PARADYM, LivaNova, Clamart, France) | Drug | Approved | Heart Failure | COMPLETED | NCT03127202 |
| ICD | Other | Phase PHASE4 | Heart Failure | TERMINATED | NCT01170624 |
| ICD | Other | Phase PHASE4 | Heart Failure | TERMINATED | NCT01170624 |
| ICD | Other | Phase PHASE4 | Heart Failure | TERMINATED | NCT01170624 |
| Ovatio VR 6250 or DR6550 | Other | Phase PHASE4 | Sudden Cardiac Death | COMPLETED | NCT00560768 |
| Ovatio VR 6250 or DR6550 | Other | Phase PHASE4 | Sudden Cardiac Death | COMPLETED | NCT00560768 |
| Ovatio VR 6250 or DR6550 | Other | Phase PHASE4 | Sudden Cardiac Death | COMPLETED | NCT00560768 |
| OVATIO DR 6550 | Other | Phase PHASE4 | Tachycardia | COMPLETED | NCT00729703 |
| Ovatio DR 6550 | Other | Phase PHASE4 | Tachycardia | COMPLETED | NCT00729703 |
| OVATIO DR 6550 | Other | Phase PHASE4 | Tachycardia | COMPLETED | NCT00729703 |
| Ovatio DR 6550 | Other | Phase PHASE4 | Tachycardia | COMPLETED | NCT00729703 |
| biological heart valve prosthesis | Other | Approved | Heart Valve Diseases | COMPLETED | NCT00377871 |
| biological heart valve prosthesis | Other | Approved | Heart Valve Diseases | COMPLETED | NCT00377871 |
| holter implantation | Other | Phase PHASE4 | Post-TAVI | UNKNOWN | NCT02482844 |
| pacemaker implantation | Other | Phase PHASE4 | Post-TAVI | UNKNOWN | NCT02482844 |
| holter implantation | Other | Phase PHASE4 | Post-TAVI | UNKNOWN | NCT02482844 |
| pacemaker implantation | Other | Phase PHASE4 | Post-TAVI | UNKNOWN | NCT02482844 |
| Cardiac Resynchronization Therapy -Defibrillator (range PARADYM, LivaNova, Clamart, France) | Drug | Approved | Heart Failure | COMPLETED | NCT03127202 |
| Kinesthetic stimulation | Other | Preclinical | Sleep Apnea, Obstructive | COMPLETED | NCT03300037 |
| Kinesthetic stimulation | Other | Preclinical | Sleep Apnea, Obstructive | COMPLETED | NCT03300037 |
| Kinesthetic stimulation | Other | Approved | Obstructive Sleep Apnea Syndrome | COMPLETED | NCT02789748 |
| Kinesthetic stimulation | Other | Approved | Obstructive Sleep Apnea Syndrome | COMPLETED | NCT02789748 |
| dual chamber pacemaker with SafeR algorithm | Other | Preclinical | Sinus Node Dysfunction | COMPLETED | NCT02586480 |
| dual chamber pacemaker with SafeR algorithm | Other | Preclinical | Sinus Node Dysfunction | COMPLETED | NCT02586480 |
| dual chamber pacemaker with SafeR algorithm | Other | Preclinical | Sinus Node Dysfunction | COMPLETED | NCT02586480 |
| Echocardiographic, polygraphy, electrocardiography measurements and sleep questionnaire | Other | Phase PHASE4 | Sleep Breathing Disorders in the Responders to Cardiac Resynchronisation Therapy (CRT) | WITHDRAWN | NCT02870647 |
| Equilia® Vagal Nerve Stimulation | Other | Phase PHASE2 | Heart Failure With Reduced Ejection Fraction | COMPLETED | NCT02113033 |
| Equilia® Vagal Nerve Stimulation | Other | Phase PHASE2 | Heart Failure With Reduced Ejection Fraction | COMPLETED | NCT02113033 |
| implantation of the new LV lead: NANO system. | Other | Phase PHASE2 | LV Lead | TERMINATED | NCT01731210 |
| implantation of the new LV lead: NANO system. | Other | Phase PHASE2 | LV Lead | TERMINATED | NCT01731210 |
| "In-Clinic LVAT" | Other | Approved | Heart Failure | COMPLETED | NCT03014180 |
| "In-Clinic LVAT" | Other | Approved | Heart Failure | COMPLETED | NCT03014180 |
| "In-Clinic LVAT" | Other | Approved | Heart Failure | COMPLETED | NCT03014180 |
| Finapres Nova device (FMS system) | Device | Approved | Healthy | COMPLETED | NCT02650232 |
| Orthostatic test | Other | Approved | Healthy | COMPLETED | NCT02650232 |
| SOMNOtouch device (Somnomedics) | Device | Approved | Healthy | COMPLETED | NCT02650232 |
| Finapres Nova device (FMS system) | Device | Approved | Healthy | COMPLETED | NCT02650232 |
| Orthostatic test | Other | Approved | Healthy | COMPLETED | NCT02650232 |
| SOMNOtouch device (Somnomedics) | Device | Approved | Healthy | COMPLETED | NCT02650232 |
| Finapres Nova device (FMS system) | Device | Approved | Healthy | COMPLETED | NCT02650232 |
| Orthostatic test | Other | Approved | Healthy | COMPLETED | NCT02650232 |
| SOMNOtouch device (Somnomedics) | Device | Approved | Healthy | COMPLETED | NCT02650232 |
| Mitroflow DL | Other | Approved | Aortic Stenosis | TERMINATED | NCT02351726 |
| Mitroflow DL | Other | Approved | Aortic Stenosis | TERMINATED | NCT02351726 |
| Mitroflow DL | Other | Approved | Aortic Stenosis | TERMINATED | NCT02351726 |
| Accelerometer Live-Streaming Tool | Other | Preclinical | Epilepsy, Tonic-Clonic | WITHDRAWN | NCT04282681 |
| Accelerometer Live-Streaming Tool | Other | Preclinical | Epilepsy, Tonic-Clonic | WITHDRAWN | NCT04282681 |
| Microburst Stimulation | Other | Approved | Epilepsies, Partial | COMPLETED | NCT03446664 |
| 3D Echocardiography | Other | Approved | Mitral Valve Disease | COMPLETED | NCT01987635 |
| Standard use of rigid ring. | Other | Approved | Mitral Valve Disease | COMPLETED | NCT01987635 |
| MEMO 3D ring | Other | Approved | Mitral Valve Disease | COMPLETED | NCT01987635 |
| VITARIA System | Other | Approved | Heart Failure | TERMINATED | NCT03425422 |
| VITARIA System | Other | Approved | Heart Failure | TERMINATED | NCT03425422 |
| VITARIA System | Other | Approved | Heart Failure | TERMINATED | NCT03425422 |
| aura6000 System | Other | Approved | Obstructive Sleep Apnea | COMPLETED | NCT02263859 |
| aura6000 System | Other | Approved | Obstructive Sleep Apnea | COMPLETED | NCT02263859 |
| aura6000 System | Other | Approved | Obstructive Sleep Apnea | COMPLETED | NCT02263859 |
| LivaNova Bioprothetic Aortic Valve Implant | Other | Approved | Aortic-valve Replacement | COMPLETED | NCT03200574 |
| 4D Cardiac CT Scan | Other | Approved | Aortic-valve Replacement | COMPLETED | NCT03200574 |
| LivaNova Bioprothetic Aortic Valve Implant | Other | Approved | Aortic-valve Replacement | COMPLETED | NCT03200574 |
| 4D Cardiac CT Scan | Other | Approved | Aortic-valve Replacement | COMPLETED | NCT03200574 |
| Vagus Nerve Stimulation (VNS) Therapy | Drug | Preclinical | Epilepsy | COMPLETED | NCT03529045 |
| Vagus Nerve Stimulation (VNS) Therapy | Drug | Preclinical | Epilepsy | COMPLETED | NCT03529045 |
| Vagus Nerve Stimulation (VNS) Therapy | Drug | Preclinical | Epilepsy | COMPLETED | NCT03529045 |
| Vagal nerve stimulation (VNS) | Other | Approved | Autoimmune Diseases | RECRUITING | NCT03953768 |
| Vagal nerve stimulation (VNS) | Other | Approved | Autoimmune Diseases | RECRUITING | NCT03953768 |
| Experimental 2 | Other | Approved | Heart Failure | WITHDRAWN | NCT01293526 |
| Experimental | Other | Approved | Heart Failure | WITHDRAWN | NCT01293526 |
| Control | Other | Approved | Heart Failure | WITHDRAWN | NCT01293526 |
| Experimental 2 | Other | Approved | Heart Failure | WITHDRAWN | NCT01293526 |
| Experimental | Other | Approved | Heart Failure | WITHDRAWN | NCT01293526 |
| Control | Other | Approved | Heart Failure | WITHDRAWN | NCT01293526 |
| Hypoglossal Nerve Stimulation | Other | Approved | Obstructive Sleep Apnea | ACTIVE_NOT_RECRUITING | NCT04950894 |
| Best Medical Treatment | Drug | Approved | Treatment Resistant Depression (TRD) | RECRUITING | NCT05952674 |
| Vagus Nerve Stimulation (VNS) | Other | Approved | Treatment Resistant Depression (TRD) | RECRUITING | NCT05952674 |
| Best Medical Treatment | Drug | Approved | Treatment Resistant Depression (TRD) | RECRUITING | NCT05952674 |
| Vagus Nerve Stimulation (VNS) | Other | Approved | Treatment Resistant Depression (TRD) | RECRUITING | NCT05952674 |
| Vagus Nerve Stimulation (VNS) | Other | Approved | Treatment Resistant Depression | RECRUITING | NCT03887715 |
| Vagus Nerve Stimulation (VNS) | Other | Approved | Treatment Resistant Depression | RECRUITING | NCT03887715 |
| Vagal Nerve Simulation (VNS) Therapy | Drug | Preclinical | Treatment Resistant Depression | RECRUITING | NCT03320304 |
| Vagal Nerve Simulation (VNS) Therapy | Drug | Preclinical | Treatment Resistant Depression | RECRUITING | NCT03320304 |
| Vagal Nerve Simulation (VNS) Therapy | Drug | Preclinical | Treatment Resistant Depression | RECRUITING | NCT03320304 |
| Attended cardiorespiratory sleep study | Other | Approved | Sleep Apnea | COMPLETED | NCT02751021 |
| pacemaker diagnostic algorithm | Other | Approved | Sleep Apnea | COMPLETED | NCT02751021 |
| Attended cardiorespiratory sleep study | Other | Approved | Sleep Apnea | COMPLETED | NCT02751021 |
| pacemaker diagnostic algorithm | Other | Approved | Sleep Apnea | COMPLETED | NCT02751021 |
Total products: 127